# AccurKardia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/accurkardia

- Industry: Software
- Headquarters: New York, US
- Website: www.accurkardia.com
- Total disclosed funding: $4.1M
- Latest round: Seed (Jun 30, 2023)
- Investors on record: 1

## About

Founded in 2019 by its CEO, Juan C. Jimenez, CPO, Mohamed Sadeq Ali, and chief scientist, Naveen Srinivas, and based in New York, US, AccurKardia Inc., operates as a software company that provides automated ECG interpretation software that helps in cardiac monitoring. In June 2023, AccurKardia raised USD 2.7 million in seed funding from the Popular Impact Fund, with participation from other unspecified investors.

The company offers clinical-grade ECG interpretation software used for cardiac-care and monitoring through data collection and analysis from Holters, event recorders, and other devices. The company’s product portfolio includes AccurECG, a cloud-based web application, AccurAPI, and AccurBeat, an iOS app for the Apple Watch ECG, along with independent clinical and scientific research solutions.

The company plans to use the June 2023 funding to introduce its technology to the market and collaborate with leading cardiology monitoring service providers.

## Funding rounds

- Seed, Jun 30, 2023, $4.1M — Popular Impact Fund

## Investors

- Popular Impact Fund (https://capitalatlas.ai/funds/popular-impact-fund) — Seed